Systematic review and meta-analysis: Is 1-week proton pump inhibitor-based triple therapy sufficient to heal peptic ulcer?

Alimentary Pharmacology and Therapeutics

Volumn 21, Issue 7, 2005, Pages 795-804

  Gisbert, J P ^a,b   Pajares, J M ^a  

^a HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

^b NONE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; CLARITHROMYCIN; ESOMEPRAZOLE; METRONIDAZOLE; OMEPRAZOLE; PROTON PUMP INHIBITOR; TETRACYCLINE; TINIDAZOLE;

ADULT; ANTIBIOTIC THERAPY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DATA ANALYSIS; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; ERADICATION THERAPY; FEMALE; HEALING; HELICOBACTER PYLORI; HUMAN; MAJOR CLINICAL STUDY; MALE; META ANALYSIS; PATIENT COMPLIANCE; PEPTIC ULCER; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REVIEW; SYSTEMATIC REVIEW; TREATMENT FAILURE; ULCER HEALING;

ANTI-BACTERIAL AGENTS; ANTI-ULCER AGENTS; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; PEPTIC ULCER; PROTON PUMPS; RANDOMIZED CONTROLLED TRIALS; TREATMENT OUTCOME;

EID: 16444386099     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2005.02418.x     Document Type: Review

References (59)

1. Malfertheiner P, Megraud F, O'Morain C, et al. Current concepts in the management of Helicobacter pylori infection - the Maastricht 2-2000 Consensus Report. Aliment. Pharmacol Ther 2002; 16: 167-80.
2. Laine L, Hopkins RJ, Girardi LS. Has the impact of Helicobacter pylori therapy on ulcer recurrence in the United States been overstated? A meta-analysis of rigorously designed trials [see comments]. Am J Gastroenterol 1998; 93: 1409-15.
3. Leodolter A, Kulig M, Brasch H, Meyer-Sabellek W, Willich SN, Malfertheiner P. A meta-analysis comparing eradication, healing and relapse rates in patients with Helicobacter pylori-associated gastric or duodenal ulcer. Aliment Pharmacol Ther 2001; 15: 1949-58.
4. Ford AC, Delaney BC, Forman D, Moayyedi P, Eradication therapy in Helicobacter pylori positive peptic ulcer disease: systematic review and economic analysis. Am J Gastroenterol 2004; 99: 1833-55.
5. Buckley M, O'Morain C. Helicobacter pylori eradication - a surrogate marker for duodenal ulcer healing. Eur J Gastroenterol Hepatol 1996; 8: 415-6.
6. Bianchi Porro G, Parente F, Lazzaroni M. Short and long term outcome of Helicobacter pylori positive resistant duodenal ulcers treated with colloidal bismuth subcitrate plus antibiotics or sucralfate alone [see comments]. Gut 1993; 34: 466-9.
7. Mantzaris GJ, Hatzis A, Tamvakologos G, Petraki K, Spiliades C, Triadaphyllou G. Prospective, randomized, investigator-blind trial of Helicobacter pylori infection treatment in patients with refractory duodenal ulcers. Healing and long-term relapse rates. Dig Dis Sci 1993; 38: 1132-6.
8. Lanas AI, Remacha B, Esteva F, Sainz R. Risk factors associated with refractory peptic ulcers [see comments]. Gastroenterology 1995; 109: 1124-33.
9. Williams MP, Pounder RE. What are appropriate end-points for Helicobacter pylori eradication in the treatment of duodenal ulcer? Drugs 1998; 56: 1-10.
10. Jadad AR, Moore RA, Carroll D, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 1996; 17: 1-12.
11. Adamek RJ, Szymanski C, Pfaffenbach B, Opferkuch W, Ricken D, Wegener M. Short-term triple therapy with pantoprazole, clarithromycin and metronidazole for the healing of Helicobacter pylori infection. Dtsch Med Wochenschr 1995; 120: 358-60.
12. Colin R. Duodenal ulcer healing with 1-week eradication triple therapy followed, or not, by anti-secretory treatment: a multicentre double-blind placebo-controlled trial. Aliment Pharmacol Ther 2002; 16: 1157-62.
13. Forne M, Viver JM, Esteve M, et al. Randomized clinical trial comparing two one-week triple-therapy regimens for the eradication of Helicobacter pylori infection and duodenal ulcer healing. Am J Gastroenterol 1998; 93: 35-8.
14. Garcia S, Fuentes J, Ducons JA, Barrera F, Yus C, Gomollon F, Is 1-week treatment for peptic ulcer healing sufficient and safe? [see comments]. Rev Esp Enferm Dig 2000; 92: 5-12.
15. Gisbert JP, Boixeda D, Martin De Argila C, Alvarez Baleriola I, Abraira V, Garcia Plaza A. Unhealed duodenal ulcers despite Helicobacter pylori eradication. Scand J Gastroenterol 1997; 32: 643-50.
16. Goh K, Parasakthi N, Cheah P, et al. Efficacy of a 1-week pantoprazole triple therapy in eradicating Helicobacter pylori in Asian patients [In Process Citation]. J Gastroenterol Hepatol 2000; 15: 910-4.
17. Goh KL, Rosaida MS, Salem O, et al. Efficacy of a 1-week rebeprazole triple therapy for eradicating Helicobacter pylori and ulcer healing: an "in-clinical-practice" study. Chin J Dig Dis 2003; 4: 204-8.
18. Gomollon F, Santolaria S, Ducons JA, Guirao R, Vera J, Montoro M. Does eliminating Helicobacter pylori mean the healing of the duodenal ulcer? The results of a prospective study in Spain. Gastroenterol Hepatol 2000; 23: 62-5.
19. Jaup BH, Norrby A. Low dose, short-term triple therapy for cure of Helicobacter pylori infection and healing of peptic ulcers. Am J Gastroenterol 1995; 90: 943-5.
20. Jaup BH, Norrby A. Comparison of two low-dose one-week triple therapy regimens with and without metronidazole for cure of H. pylori infection. Aliment Pharmacol Ther 1996; 10: 275-7.
21. Harris AW, Misiewicz JJ, Bardhan KD, et al. Incidence of duodenal ulcer healing after 1 week of proton pump inhibitor triple therapy for eradication of Helicobacter pylori. The Lansoprazole Helicobacter Study Group. Aliment Pharmacol Ther 1998; 12: 741-5.
22. Higuchi K, Fujiwara Y, Tominaga K, et al. Is eradication sufficient to heal gastric ulcers in patients infected with Helicobacter pylori? A randomized, controlled, prospective study. Aliment Pharmacol Ther 2003; 17: 111-7.
23. Hsu CC, Lu SN, Changchien CS. One-week low-dose triple therapy without anti-acid treatment has sufficient efficacy on Helicobacter pylori eradication and ulcer healing. Hepatogastroenterology 2003; 50: 1731-4.
24. Labenz J, Tillenburg B, Peitz U, et al. Ulcer healing through the elimination of Helicobacter pylori: is a week of therapy enough? Dtsch Med Wochenschr 1996; 121: 3-7; discussion 7-8.
25. Labenz J, Idstrom JP, Tillenburg B, Peitz U, Adamek RJ, Borsch G. One-week low-dose triple therapy for Helicobacter pylori is sufficient for relief from symptoms and healing of duodenal ulcers. Aliment Pharmacol Ther 1997; 11: 89-93.
26. Marzio L, Cellini L, Angelucci D. Triple therapy for 7 days vs. triple therapy for 7 days plus omeprazole for 21 days in treatment of active duodenal ulcer with Helicobacter pylori infection. A double blind placebo controlled trial. Dig Liver Dis 2003; 35: 20-3.
27. Schutze K, Hentschel E. Duodenal ulcer healing after 7-day treatment: a pilot study with lansoprazole, amoxicillin and clarithromycin. Z Gastroenterol 1995; 33: 651-3.
28. Schutze K, Hentschel E, Hirschl AM. Effect of omeprazole and amoxicillin plus metronidazole on the eradication of Helicobacter pylori and the healing of duodenal ulcer: comparison with a historical control. Hepatogastroenterology 1999; 46: 2358-62.
29. Spinzi GC, Bierti L, Bortoli A, et al. Comparison of omeprazole and lansoprazole in short-term triple therapy for Helicobacter pylori infection. Aliment Pharmacol Ther 1998; 12: 433-8.
30. Spinzi GC, Boni F, Bortoli A, et al. Seven-day triple therapy with ranitidine bismuth citrate or omeprazole and two antibiotics for eradication of Helicobacter pylori in duodenal ulcer: a multicentre, randomized, single-blind study. Aliment Pharmacol Ther 2000; 14: 325-30.
31. Sung JJ, Leung WK, Ling TK, et al. One-week use of ranitidine bismuth citrate, amoxycillin and clarithromycin for the treatment of Helicobacter pylori-related duodenal ulcer. Aliment Pharmacol Ther 1998; 12: 725-30.
32. Tepes B, Krizman I, Gorensek M, Gubina M, Orel I. Is a one-week course of triple anti-Helicobacter pylori therapy sufficient to control active duodenal ulcer? Aliment Pharmacol Ther 2001; 15: 1037-45.
33. Tulassay Z, Kryszewski A, Dite P, et al. One week of treatment with esomeprazole-based triple therapy eradicates Helicobacter pylori and heals patients with duodenal ulcer disease. Eur J Gastroenterol Hepatol 2001; 13: 1457-65.
34. Wheeldon TU, Hoang TT, Phung DC, Bjorkman A, Granstrom M, Sorberg M. Helicobacter pylori eradication and peptic ulcer healing: the impact of deleting the proton pump inhibitor and using a once-daily treatment. Aliment Pharmacol Ther 2003; 18: 93-100.
35. Lam SK, Lee NW, Koo J, Hui WM, Fok KH, Ng M. Randomised crossover trial of tripotassium dicitrato bismuthate versus high dose cimetidine for duodenal ulcers resistant to standard dose of cimetidine. Gut 1984; 25: 703-6.
36. Porro GB, Parente F, Lazzaroni M, Tripotassium dicitrato bismuthate (TDB) versus two different dosages of cimetidine in the treatment of resistant duodenal ulcers. Gut 1987; 28: 907-11.
37. Graham DY, Lew GM, Evans DG, Evans DJ Jr, Klein PD. Effect of triple therapy (antibiotics plus bismuth) on duodenal ulcer healing. A randomized controlled trial. Ann Intern Med 1991; 115: 266-9.
38. Hosking SW, Ling TK, Yung MY, et al. Randomised controlled trial of short term treatment to eradicate Helicobacter pylori in patients with duodenal ulcer [see comments]. Bmj 1992; 305: 502-4.
39. Hentschel E, Brandstatter G, Dragosics B, et al. Effect of ranitidine and amoxicillin plus metronidazole on the eradication of Helicobacter pylori and the recurrence of duodenal ulcer [see comments]. N Engl J Med 1993; 328: 308-12.
40. O'Connor HJ, Kanduru C, Bhutta AS, Meehan JM, Feeley KM, Cunnane K. Effect of Helicobacter pylori eradication on peptic ulcer healing. Postgrad Med J 1995; 71: 90-3.
41. Treiber G, Lambert JR. The impact of Helicobacter pylori eradication on peptic ulcer healing. Am J Gastroenterol 1998; 93: 1080-4.
42. Wilde MI, McTavish D, Omeprazole. An update of its pharmacology and therapeutic use in acid-related disorders. Drugs 1994; 48: 91-132.
43. Dupas JL, Corallo J, Helbert T, Zaim M. Acid suppression therapy is not required after one-week anti-Helicobacter pylori triple therapy for duodenal ulcer healing. Gastroenterol Clin Biol 2000; 24: 638-43.
44. Marchi S, Costa F, Bellini M, et al. Ranitidine bismuth citrate-based triple therapy for seven days, with or without further anti-secretory therapy, is highly effective in patients with duodenal ulcer and Helicobacter pylori infection. Eur J Gastroenterol Hepatol 2001; 13: 547-50.
45. Kamberoglou D, Polymeros D, Sanidas I, et al. Comparison of 1-week vs. 2- or 4-week therapy regimens with ranitidine bismuth citrate plus two antibiotics for Helicobacter pylori eradication. Aliment Pharmacol Ther 2001; 15: 1493-7.
46. Forne M, Viver JM, Espinos JC, Coll I, Tresserra F, Garau J. Impact of colloidal bismuth subnitrate in the eradication rates of Helicobacter pylori infection-associated duodenal ulcer using a short treatment regimen with omeprazole and clarithromycin: a randomized study [see comments]. Am J Gastroenterol 1995; 90: 718-21.
47. Zheng ZT, Wang ZY, Chu YX, et al. Double-blind short-term trial of furazolidone in peptic ulcer. Lancet 1985; 1: 1048-9.
48. Hosking SW, Ling TK, Chung SC, et al. Duodenal ulcer healing by eradication of Helicobacter pylori without anti-acid treatment: randomised controlled trial [see comments]. Lancet 1994; 343: 508-10.
49. Sung JJ, Chung SC, Ling TK, et al. Antibacterial treatment of gastric ulcers associated with Helicobacter pylori [see comments]. N Engl J Med 1995; 332: 139-42.
50. Lam SK, Ching CK, Lai KC, et al. Does treatment of Helicobacter pylori with antibiotics alone heal duodenal ulcer? A randomised double blind placebo controlled study [see comments]. Gut 1997; 41: 43-8.
51. Ge ZZ, Zhang DZ, Xiao SD, Chen Y, Hu YB. Does eradication of Helicobacter pylori alone heal duodenal ulcers? Aliment Pharmacol Ther 2000; 14: 53-8.
52. Massarrat S, Ihm P, Koch HK. Efficacy of tetracycline and metronidazole alone or with ranitidine on the healing of duodenal ulcer and eradication of Helicobacter pylori. A randomized controlled multicenter study. Tetra-Metro-Ran Study Group. Arzneimittelforschung 1998; 48: 686-90.
53. Ng EK, Lam YH, Sung JJ, et al. Eradication of Helicobacter pylori prevents recurrence of ulcer after simple closure of duodenal ulcer perforation: randomized controlled trial [see comments]. Ann Surg 2000; 231: 153-8.
54. el-Omar EM, Penman ID, Ardill JE, Chittajallu RS, Howie C, McColl KE. Helicobacter pylori infection and abnormalities of acid secretion in patients with duodenal ulcer disease [see comments]. Gastroenterology 1995; 109: 681-91.
55. Hogan DL, Rapier RC, Dreilinger A, et al. Duodenal bicarbonate secretion: eradication of Helicobacter pylori and duodenal structure and function in humans [see comments], Gastroenterology 1996; 110: 705-16.
56. Hopkins RJ, Girardi LS, Turney EA. Relationship between Helicobacter pylori eradication and reduced duodenal and gastric ulcer recurrence: a review. Gastroenterology 1996; 110: 1244-52.
57. Bermejo F, Boixeda D, Martin De Argila C, et al. Healing of Helicobacter pylori gastric ulcers: only eradication matters. Rev Esp Enferm Dig 2003; 95: 621-4.
58. Hunt RH, Cederberg C, Dent J, et al. Optimizing acid suppression for treatment of acid-related diseases. Dig Dis Sci 1995; 40: 24S-49S.
59. Lai KC, Hui WM, Wong BC, Hu WH, Lam SK. Ulcer-healing drugs are required after eradication of Helicobacter pylori in patients with gastric ulcer but not duodenal ulcer haemorrhage. Aliment Pharmacol Ther 2000; 14: 1071-6.